Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement
Randall A. Oyer(Lancaster General Hospital), Lori J. Pierce(University of Michigan–Ann Arbor), Amelie G. Ramírez(Novartis (Switzerland)), Nadine J. Barrett(Novartis (Switzerland)), Carmen E. Guerra(Novartis (Switzerland)), Leslie Byatt(Novartis (Switzerland)), Sybil Green(Novartis (Switzerland)), Leigh Boehmer(Novartis (Switzerland)), Marjory Charlot(University of North Carolina at Chapel Hill), J.E. Caerwyn Williams(Novartis (Switzerland)), Patricia A. Hurley(Dana-Farber Brigham Cancer Center), Julie R. Gralow(American Society of Clinical Oncology), Elizabeth Garrett‐Mayer(Novartis (Switzerland)), Suanna S. Bruinooge(Dana-Farber Brigham Cancer Center), Al B. Benson(Northwestern University), Manali I. Patel(Palo Alto University), Eddy S. Yang(University of Kentucky), Khalid Matin(Virginia Cancer Institute), Worta McCaskill‐Stevens(National Cancer Institute), Claudia M. Hardy(Novartis (Switzerland)), Victoria Zwicker(Novartis (Switzerland)), Janette K. Merrill(Institute of Cancer Research), Kathryn Levit(Novartis (Switzerland)), Karen M. Winkfield(Atrium Health Wake Forest Baptist), Mel Mann(Novartis (Switzerland)), Grzegorz S. Nowakowski(Université Claude Bernard Lyon 1), Jen Hanley Williams(Novartis (Switzerland)), Jennie R. Crews(CancerCare Manitoba), Alice Pressman(Kaiser Permanente), Lea Ann Bernick(Sutter Health), Lola A. Fashoyin‐Aje(Center for Drug Evaluation and Research), Kyle DeLeon(Novartis (Switzerland)), Leila Hamroun(Novartis (Switzerland)), Sanford Jeames, Bridgette Hempstead(Novartis (Switzerland)), Juanita Segura(Novartis (Switzerland))
Cited by 238
Related Papers
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer
|Journal of Clinical Oncology|2004|1.5k
Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2017|1.4k
NCCN Guidelines Insights: Colon Cancer, Version 2.2018
|Journal of the National Comprehensive Cancer Network|2018|1k